ARTICLE | Company News
Cellectis, National Institutes of Health (NIH) gene/cell therapy news
October 22, 2012 7:00 AM UTC
NIH awarded Cellectis' commercial subsidiary, Cellectis bioresearch Inc., a contract worth up to $9.5 million over five years. Cellectis will generate induced pluripotent stem (iPS) cell lines of clin...